152 related articles for article (PubMed ID: 8901435)
1. Anti-human immunodeficiency virus type 1 activities of dideoxynucleoside phosphotriester derivatives in primary monocytes/macrophages.
Thumann-Schweitzer C; Gosselin G; Périgaud C; Benzaria S; Girardet JL; Lefebvre I; Imbach JL; Kirn A; Aubertin AM
Res Virol; 1996; 147(2-3):155-63. PubMed ID: 8901435
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives.
Balzarini J
Pharm World Sci; 1994 Apr; 16(2):113-26. PubMed ID: 8032337
[TBL] [Abstract][Full Text] [Related]
4. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Webb DS; Hao Z; Mitsuya H; Johns DG; Broder S
J Exp Med; 1989 Mar; 169(3):933-51. PubMed ID: 2538549
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition of HIV reproduction in cell culture by 5'-phosphonates of 3'-azido-2',3'-dideoxynucleosides].
Tarusova NB; Khorlin AA; Kraevskiĭ AA; Korneeva MN; Nosik DN; Kruglov IV; Galegov GA; Bibilashvili RSh
Mol Biol (Mosk); 1989; 23(6):1716-24. PubMed ID: 2633042
[TBL] [Abstract][Full Text] [Related]
6. Activities of masked 2',3'-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophages.
Aquaro S; Wedgwood O; Yarnold C; Cahard D; Pathinara R; McGuigan C; Calio' R; de Clercq E; Balzarini J; Perno CF
Antimicrob Agents Chemother; 2000 Jan; 44(1):173-7. PubMed ID: 10602742
[TBL] [Abstract][Full Text] [Related]
7. Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2',3'-dideoxynucleoside analogs in resting and activated human cells.
Gao WY; Agbaria R; Driscoll JS; Mitsuya H
J Biol Chem; 1994 Apr; 269(17):12633-8. PubMed ID: 8175673
[TBL] [Abstract][Full Text] [Related]
8. Marked inhibitory activity of masked aryloxy aminoacyl phosphoramidate derivatives of dideoxynucleoside analogues against visna virus infection.
Balzarini J; Cahard D; Wedgwood O; Salgado A; Velázquez S; Yarnold CJ; De Clercq E; McGuigan C; Thormar H
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):296-302. PubMed ID: 9525429
[TBL] [Abstract][Full Text] [Related]
9. Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages.
Perno CF; Cooney DA; Gao WY; Hao Z; Johns DG; Foli A; Hartman NR; Caliò R; Broder S; Yarchoan R
Blood; 1992 Aug; 80(4):995-1003. PubMed ID: 1379854
[TBL] [Abstract][Full Text] [Related]
10. Anti-HIV activity of novel phosphonate derivatives of AZT, d4T, and ddA.
Pokrovsky AG; Pronayeva TR; Fedyuk NV; Shirokova EA; Khandazhinskaya AL; Tarusova NB; Karpenko IL; Krayevsky AA
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):767-9. PubMed ID: 11563112
[TBL] [Abstract][Full Text] [Related]
11. Equal inhibition of the replication of human immunodeficiency virus in human T-cell culture by ddA bis(SATE)phosphotriester and 3'-azido-2',3'-dideoxythymidine.
Perigaud C; Aubertin AM; Benzaria S; Pelicano H; Girardet JL; Maury G; Gosselin G; Kirn A; Imbach JL
Biochem Pharmacol; 1994 Jul; 48(1):11-14. PubMed ID: 8043011
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells.
Shirasaka T; Chokekijchai S; Yamada A; Gosselin G; Imbach JL; Mitsuya H
Antimicrob Agents Chemother; 1995 Nov; 39(11):2555-9. PubMed ID: 8585744
[TBL] [Abstract][Full Text] [Related]
13. [What is known about the cellular and molecular pharmacodynamics of nucleosides?].
Sommadossi JP
Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):781-7. PubMed ID: 8309721
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-HIV activity of some novel arylphosphate and H-phosphonate derivatives of 3'-azido-2',3'-dideoxythymidine and 2',3'-didehydro-2',3'-dideoxythymidine.
Cardona VM; Ayi AI; Aubertin AM; Guedj R
Antiviral Res; 1999 Jul; 42(3):189-96. PubMed ID: 10443531
[TBL] [Abstract][Full Text] [Related]
15. Potential prodrug derivatives of 2',3'-didehydro-2',3'-dideoxynucleosides. Preparations and antiviral activities.
Mullah KB; Rao TS; Balzarini J; De Clercq E; Bentrude WG
J Med Chem; 1992 Jul; 35(15):2728-35. PubMed ID: 1495007
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-HIV evaluation of D4T and D4T 5'-monophosphate prodrugs.
Sergheraert C; Pierlot C; Tartar A; Henin Y; Lemaitre M
J Med Chem; 1993 Apr; 36(7):826-30. PubMed ID: 8385224
[TBL] [Abstract][Full Text] [Related]
17. Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT).
Parang K; Wiebe LI; Knaus EE
Curr Med Chem; 2000 Oct; 7(10):995-1039. PubMed ID: 10911016
[TBL] [Abstract][Full Text] [Related]
18. Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus.
Balzarini J; Kruining J; Wedgwood O; Pannecouque C; Aquaro S; Perno CF; Naesens L; Witvrouw M; Heijtink R; De Clercq E; McGuigan C
FEBS Lett; 1997 Jun; 410(2-3):324-8. PubMed ID: 9237655
[TBL] [Abstract][Full Text] [Related]
19. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
Cinatl J; Cinatl J; Weber B; Rabenau H; Weissflog A; Mainke M; Kornhuber B; Doerr HW
Acta Virol; 1993 Oct; 37(5):360-8. PubMed ID: 8184788
[TBL] [Abstract][Full Text] [Related]
20. Anti-human immunodeficiency virus type 1 activity of hydroxyurea in combination with 2',3'-dideoxynucleosides.
Gao WY; Johns DG; Mitsuya H
Mol Pharmacol; 1994 Oct; 46(4):767-72. PubMed ID: 7969058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
